Conclusion
Although further studies, including unveiling molecular mechanisms and clinical trials, are necessary, we can conclude that administration of supraphysiological doses of T with a rapid drop to castration levels (BAT) might re-sensitize cancer cells to non-steroidal antiandrogens and restore resistance to other treatment modalities including ARAT and cytotoxic chemotherapy.